Question 1

Does Aberdeen Group own EWTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Aberdeen Group holds 647,926 shares of EWTX (Edgewise Therapeutics), worth $26.3M.

Question 2

How many shares of EWTX does Aberdeen Group own?

Accepted Answer

As of its Q2 2026 13F, Aberdeen Group holds 647,926 shares of EWTX (Edgewise Therapeutics).

Question 3

What is Aberdeen Group's EWTX position worth?

Accepted Answer

As of its Q2 2026 13F, Aberdeen Group's EWTX position is worth $26.3M.

Question 4

Is Aberdeen Group buying or selling EWTX?

Accepted Answer

In Q2 2026, Aberdeen Group reduced its EWTX position by 178,133 shares (-21.6%).

Question 5

When did Aberdeen Group first buy EWTX?

Accepted Answer

Aberdeen Group first reported EWTX in its Q4 2023 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	647,926	-21.6%	$26.3M	0.0%	$40.63	0
2026-Q1	Increased	826,059	+0.5%	$26M	0.0%	$28.81	29
2025-Q4	Increased	821,940	+32.6%	$20.4M	0.0%	$24.54	36
2025-Q3	Increased	619,878	+39.8%	$10.1M	0.0%	$15.75	37
2025-Q2	Increased	443,319	+41.6%	$5.8M	0.0%	$13.17	36
2025-Q1	Increased	313,025	+75.8%	$6.9M	0.0%	$23.27	41
2024-Q4	Decreased	178,043	-30.6%	$4.8M	0.0%	$27.06	0
2024-Q3	New	256,645	-	$6.8M	0.0%	$26.09	38
2024-Q1	Exited	0	-100.0%	$0	0.0%	$18.24	0
2023-Q4	New	150,418	-	$1.6M	0.0%	$10.94	36

EWTX10 quarters

EWTX
10 quarters